Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07177183 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure

Study acronym: SECRET-VENT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Oct 2026 to Dec 31, 2027
    • Start date: Oct 1, 2025 to Feb 2, 2026
    • Study sites: 4 to 2
    • Study completion date: Dec 31, 2026 to Feb 2, 2028
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective of the study is to determine whether a subnormal serum creatinine value upon admission to the Post-ICU Care Unit predicts the need for prolonged ventilatory support. A parallel objective of the study is to determine whether exogenous in-take of the dietary supplement creatine in patients with subnormal serum creatinine value is associated with a shortened duration of ventilatory support and improved patients outcome.
Trial Details
NCT Number NCT07177183
Lead Sponsor University Hospital Ostrava
Conditions
(from sponsor)		 Prolonged Mechanical Ventilation, Critical Illness
Related terms Critical Illness
Enrollment 492 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov